These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27377080)

  • 21. Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer.
    Ali MH; Ismail IY; Eltobgy A; Gobeish A
    J Endourol; 2010 Dec; 24(12):2047-50. PubMed ID: 20929433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
    Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
    Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
    Schumacher MC; Holmäng S; Davidsson T; Friedrich B; Pedersen J; Wiklund NP
    Eur Urol; 2010 Feb; 57(2):293-9. PubMed ID: 19913351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive bladder cancers?].
    Lipsker A; Hammoudi Y; Parier B; Drai J; Bahi R; Bessede T; Patard JJ; Pignot G
    Prog Urol; 2014 Sep; 24(10):640-5. PubMed ID: 25214293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
    Minardi D; Milanese G; Parri G; Lacetera V; Muzzonigro G
    Arch Ital Urol Androl; 2016 Mar; 88(1):13-6. PubMed ID: 27072170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A re-staging transurethral resection predicts early progression of superficial bladder cancer.
    Herr HW; Donat SM
    BJU Int; 2006 Jun; 97(6):1194-8. PubMed ID: 16566813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
    Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
    J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA; Kashmoula DM; Haddad LF
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion.
    Lee CT; Dunn RL; Ingold C; Montie JE; Wood DP
    Urology; 2007 Jun; 69(6):1068-72. PubMed ID: 17572188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].
    Danil'chenko DI; Koenig F; Riedl K; Schnorr D; Waldman A; Al-Shukri S; Loening SA
    Vopr Onkol; 2003; 49(6):734-7. PubMed ID: 14976918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endoscopic resection. Aspects of technique and optimization of outcomes. Current indications to PDD-guided resection].
    Pomara G; Francesca F
    Urologia; 2013; 80 Suppl 21():16-9. PubMed ID: 23559133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
    Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
    Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art].
    Kausch von Schmeling I
    Aktuelle Urol; 2010 Sep; 41(5):307-15. PubMed ID: 20824576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor.
    Kim W; Song C; Park S; Kim J; Park J; Kim SC; Cho YM; Hong B; Ahn H
    J Endourol; 2012 Aug; 26(8):1059-64. PubMed ID: 22390720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence.
    Naselli A; Introini C; Timossi L; Spina B; Fontana V; Pezzi R; Germinale F; Bertolotto F; Puppo P
    Eur Urol; 2012 May; 61(5):908-13. PubMed ID: 22280855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
    Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
    Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.